Subclasses of adenosine receptors in the central nervous system: Interaction with caffeine and related methylxanthines

Overview of attention for article published in Cellular and Molecular Neurobiology, March 1983

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)

Mentioned by

patent: 7 patents

Citations

dimensions_citation: 398 Dimensions

Readers on

mendeley: 100 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 7 patents that reference this research output.

A2A receptor antogonists for use in the treatment of movement disorders

Application EP-2942082-A2

European Patent Office

Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease

Grant US-8193200-B2

United States of America

A2A receptor antogonists for use in the treatment of movement disorders

Application EP-2260850-A2

European Patent Office

Methods of treating patients suffering from movement disorders

Application EP-2044940-A2

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 3 additional patents.